“Beyond Glucose: Empagliflozin’s Impact on Fatty Liver in Patients With Type 2 Diabetes; A True Game Changer”. 2025. Indus Journal of Bioscience Research 3 (2): 193-98. https://doi.org/10.70749/ijbr.v3i2.663.